Anti-C. pneumoniae LPS Monoclonal antibody (DMABT-51147MC)
Mouse Anti-C. pneumoniae LPS Monoclonal antibody for ELISA
Bring this labeled antibody directly to your bench!
Add to basket
ELISA: 0 - 1/2,000
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
C.pneumoniae; Chlamydophila pneumoniae; TWAR; Bacteria; Chlamydiae; Chlamydiales
Since the description in 1986 of Chlamydia pneumoniae as a pathogen it has become recognized as a common infectious agent all over the world. C. pneumoniae is primarily a respiratory tract pathogen that causes approximately 10-20% of community acquired pneumonia in adults and children, and 10-20% of acute bronchitis in adults. It also causes sinusitis, primary pharyngitis, and may trigger for asthma. Most of infections with this micro-organism are in fact subclinical and asymptomatic and only rarely cause on overt disease. Chronic infection with C. pneumoniae has been suggested as a factor in the development of atherosclerosis. Seroepidemiologic studies in different populations suggest that the seroprevalence increases sharply in young children and adolescence. After adolescence the seroprevalence continues to increase and may achieve almost complete saturation for IgG and IgA-class antibodies in the senescence. To date, most investigations have relied on serologic diagnosis. Early studies have been performed with a complement fixation (CF) test which is genus-specific and is more likely to be positive in initial infection than during reinfection. The microimmunofluorescence (MIF) method is species-specific, but requires a skilled interpreter and is not suitable for automation and high volume testing. Those technical problems are avoided with the EIA methods developed by Ani Labystems, providing easy, fast and objective tests.
Have you cited DMABT-51147MC in a publication? Let us know
and earn a reward for your research.
Nakou, A; Papaparaskevas, J; et al. A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease. FUTURE MICROBIOLOGY 9:1251-1260(2014).
Baghal, SML; Gargari, SLM; et al. Production and immunogenicity of recombinant ferric enterobactin protein (FepA). INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 14:E166-E170(2010).
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody.